PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
125.83%
Net income growth 1.25-1.5x CRK's 91.05%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
16.33%
Less D&A growth vs. CRK's 354.75%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
200.00%
Lower deferred tax growth vs. CRK's 3206.16%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-67.95%
Both cut yoy SBC, with CRK at -24.93%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
395.28%
Slight usage while CRK is negative at -209.26%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
94.37%
AR growth while CRK is negative at -1802.99%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
791.67%
Some yoy usage while CRK is negative at -103.93%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-52.50%
Both negative yoy, with CRK at -78.51%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
86.32%
Some CFO growth while CRK is negative at -96.42%. John Neff would note a short-term liquidity lead over the competitor.
12.10%
Some CapEx rise while CRK is negative at -183.21%. John Neff would see competitor possibly building capacity while we hold back expansions.
-80.43%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-107.62%
Both yoy lines negative, with CRK at -86.46%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-17.57%
Both yoy lines negative, with CRK at -293.79%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.82%
Buyback growth of 43.82% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.